oxazoles has been researched along with Lung Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azam, SH; Fussell, SC; Hwang, D; Kabanov, AV; Pecot, CV; Sokolsky-Papkov, M; Van Swearingen, AED; Vinod, N; Wayne, E | 1 |
1 other study(ies) available for oxazoles and Lung Adenocarcinoma
| Article | Year |
|---|---|
High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adjuvants, Immunologic; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Oxazoles; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Microenvironment | 2020 |